Skip to main content
padlock icon - secure page this page is secure

Continuous infusion of amphotericin B deoxycholate: an innovative, low-cost strategy in antifungal treatment

Buy Article:

$69.00 + tax (Refund Policy)


The combination of amphotericin B and sodium deoxycholate is the formulation most used in clinical practice. The development of new agents such as amphotericin with lipid formulations, caspofungin, voriconazole and other azolic derivatives, promoted alternatives to amphotericin B deoxycholate. However, because of the high cost of these new drugs, their use is difficult in a scenario of limited resources. A few strategies have been devised to make the use of amphotericin B deoxycholate less toxic. In this review, we seek to describe the accumulated knowledge about this molecule, with focus on its use in continuous infusion, which appears to be an alternative to reduce toxicity, while maintaining its clinical efficacy.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Amphotericin B deoxycholate; continuous infusion; efficacy; low cost; nephrotoxicity; toxicity

Document Type: Review Article

Publication date: March 1, 2011

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more